| Name | Title | Contact Details |
|---|
Joint Active Systems is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
United Medical Equipment Company is a Lincolnwood, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lifelines Neurodiagnostic Systems is a Troy, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For more than 30 years, Immucor has been a proud partner to thousands of hospitals, reference laboratories and donor centers. We remain focused on continuing to innovate as we work to advance the science of transfusion and transplantation diagnostics. We are guided by our corporate Mission and Values. We strive to create a world where anyone, anywhere in need of blood or an organ gets the right blood or organ that is safe, accessible and affordable. We will be guided by our Core Values of Respect, Integrity, Teamwork and Achievement. In doing so, we will: • strive to achieve the highest quality products and solutions; • bring forth and pursue innovations that advance patient safety; • honor our customers with the highest level of service.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.